GB Patent

GB2212396A — Dietary supplement comprising calcium and delayed release coated iron

Assigned to Procter and Gamble Co · Expires 1989-07-26 · 37y expired

What this patent protects

A dietary calcium and iron supplement for oral ingestion comprises a nutritionally effective amount of a composition comprising iron, a delayed release coating surrounding said iron composition which delays release of said iron from said coating, and a nutritionally effective amo…

USPTO Abstract

A dietary calcium and iron supplement for oral ingestion comprises a nutritionally effective amount of a composition comprising iron, a delayed release coating surrounding said iron composition which delays release of said iron from said coating, and a nutritionally effective amount of a substantially immediate release composition comprising calcium. After the supplement reaches the stomach, the calcium is rapidly available for entry into the small intestine while the release of the iron in the small intestine is delayed for at least one hour after the entry of the calcium into the small intestine. As a result, calcium and iron can be simultaneously delivered without adverse mineral interactions.

Drugs covered by this patent

Patent Metadata

Patent number
GB2212396A
Jurisdiction
GB
Classification
—
Expires
1989-07-26
Drug substance claim
No
Drug product claim
No
Assignee
Procter and Gamble Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.